Top 50 Life Science Startup Investors in Denmark (November 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Novo Holdings
VC Fund
|
8 | United States, Denmark, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $9.5M–$135M |
|
2xN
VC Fund
|
5 | Denmark, United States, United Kingdom | Seed, Series A, Series B | Software, Information Technology, Quantum Computing | $1.9M–$125M |
|
BioInnovation Institute
VC Fund
|
4 | Denmark, Germany, Switzerland | Convertible Note, Pre-Seed, Seed | Biotechnology, Medical, Health Care | $495k–$5.2M |
|
Export and Investment Fund
VC Fund
|
3 | Denmark, United States, Norway | Seed, Pre-Seed, Series A | Software, Biotechnology, Health Care | $395k–$84M |
|
Bioqube Ventures
VC Fund
|
3 | United States, France, Norway | Seed, Series A, Series B | Biotechnology, Therapeutics, Life Science | $4M–$108M |
|
Vaekstfonden
VC Fund
|
2 | Denmark, United States, United Kingdom | Seed, Venture - Series Unknown, Pre-Seed | Software, Information Technology, SaaS | $384k–$23M |
|
VF Venture
VC Fund
|
2 | Denmark, United Kingdom, Iceland | Seed, Series A, Venture - Series Unknown | Software, Biotechnology, Medical Device | $1.2M–$31M |
|
Balderton Capital
VC Fund
|
2 | United Kingdom, United States, Germany | Series A, Series B, Series C | Software, Artificial Intelligence, Financial Services | $3.7M–$160M |
|
Sunstone Life Science Ventures
VC Fund
|
2 | Denmark, Sweden, Switzerland | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $4.1M–$63M |
|
Nordic Alpha Partners
VC Fund
|
2 | Denmark, Germany, Sweden | Venture - Series Unknown, Seed | Energy, Energy Storage, Renewable Energy | $3M–$9.8M |
|
Wellcome Trust
VC Fund
|
2 | United States, United Kingdom, France | Grant, Series C, Series B | Biotechnology, Health Care, Medical | $1.6M–$127M |
|
Seventure Partners
VC Fund
|
2 | France, United States, Germany | Series A, Series B, Seed | Biotechnology, Software, Health Care | $1.1M–$63M |
|
Northzone
VC Fund
|
2 | United States, Sweden, United Kingdom | Series A, Series B, Seed | Software, Artificial Intelligence, FinTech | $2.4M–$100M |
|
BlueYard Capital
VC Fund
|
1 | United States, Germany, United Kingdom | Seed, Series A, Venture - Series Unknown | Software, Biotechnology, Blockchain | $1.5M–$47M |
|
David Helgason
Angel
|
1 | United States, Denmark, Finland | Seed, Series A, Pre-Seed | Software, Gaming, Artificial Intelligence | $242k–$30M |
|
Biofund
VC Fund
|
1 | Italy, Canada, Denmark | Pre-Seed, Seed | Genetics, Health Care, Health Diagnostics | |
|
Ysios Capital
VC Fund
|
1 | Spain, United States, Switzerland | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $3.8M–$135M |
|
LF Investment
VC Fund
|
1 | Denmark | Series B, Series C | Medical, Wellness, Health Care | |
|
Nucleus Capital
VC Fund
|
1 | Germany, United Kingdom, United States | Pre-Seed, Seed, Series A | Biotechnology, Food and Beverage, Manufacturing | $486k–$17M |
|
Bas Godska
Angel
|
1 | United States, The Netherlands, United Kingdom | Seed, Pre-Seed, Angel | Software, Artificial Intelligence, SaaS | $90k–$2M |
|
Per Falholt
Angel
|
1 | Denmark | Pre-Seed, Series A, Seed | Biotechnology, Robotics, Biopharma | $5.9M–$20M |
|
Noble Resources
VC Fund
|
1 | Denmark, United Kingdom | Medical, Health Care, Genetics | ||
|
Steen Riisgaard
Angel
|
1 | Denmark | Pre-Seed, Series A | Biotechnology, Biopharma, Wholesale | |
|
Redstone.VC
VC Fund
|
1 | Germany, Finland, Switzerland | Seed, Series A, Pre-Seed | Software, Information Technology, Artificial Intelligence | $460k–$17M |
|
2degrees
VC Fund
|
1 | Denmark, Vietnam | Seed, Venture - Series Unknown | Software, Logistics, Quantum Computing | $1.9M–$11M |
|
Innovestor
VC Fund
|
1 | Finland, Sweden, Denmark | Seed, Venture - Series Unknown, Pre-Seed | Software, Health Care, Information Technology | $204k–$5.1M |
|
Industrifonden
VC Fund
|
1 | Sweden, United States, Denmark | Series A, Venture - Series Unknown | Biotechnology, Software, Information Technology | $1.6M–$21M |
|
Amino Collective
VC Fund
|
1 | United States, United Kingdom, Germany | Seed, Series A, Pre-Seed | Biotechnology, Health Care, Artificial Intelligence | $125k–$37M |
|
Danske Bank
VC Fund
|
1 | Sweden, Finland, United Kingdom | Post-IPO Debt, Debt Financing | Manufacturing, Energy, Financial Services | $1.1M–$928M |
|
Delphinus Venture Capital
VC Fund
|
1 | Denmark | Seed, Venture - Series Unknown, Pre-Seed | Health Care, Food and Beverage, Wellness | $1.7M–$8.1M |
|
GGV Capital
VC Fund
|
1 | United States, China, Singapore | Series B, Series A, Series C | Software, Information Technology, Artificial Intelligence | $4.9M–$150M |
|
Teknoinvest
VC Fund
|
1 | Sweden, Norway, United States | Series B, Series A | Health Care, Biotechnology, Medical | $1.2M–$31M |
|
p53
VC Fund
|
1 | Norway, Denmark, The Netherlands | Series A | Biotechnology, Medical, Life Science | $30M–$81M |
|
Innovation Fund Denmark
VC Fund
|
1 | Denmark, United States | Grant, Pre-Seed, Seed | Software, Biotechnology, SaaS | $38k–$2.1M |
|
Seed Capital
VC Fund
|
1 | Denmark, United States, United Kingdom | Seed, Venture - Series Unknown, Series A | Software, Health Care, Information Technology | $549k–$17M |
|
Korys
VC Fund
|
1 | Belgium, The Netherlands, Germany | Series B, Series A | Biotechnology, Renewable Energy, Information Technology | $4.4M–$50M |
|
Swisscanto Private Equity
VC Fund
|
1 | Switzerland, Germany, Belgium | Series B, Series C | Health Care, Manufacturing, Robotics | |
|
Fåhraeus Startup and Growth
VC Fund
|
1 | Sweden, Denmark, Finland | Seed, Series A | Medical, Biotechnology, Genetics | $772k–$2.7M |
|
Verve Ventures
VC Fund
|
1 | Switzerland, Germany, France | Series A, Seed, Series B | Health Care, Software, Biotechnology | |
|
ATP
VC Fund
|
1 | Denmark | Series B | Health Care, Health Diagnostics, Software | |
|
Dreamcraft Ventures
VC Fund
|
1 | Denmark, United Kingdom, Germany | Seed, Pre-Seed, Series A | Software, Information Technology, Artificial Intelligence | $500k–$16M |
|
RA Capital Management
VC Fund
|
1 | United States, United Kingdom, China | Series B, Post-IPO Equity, Series A | Biotechnology, Health Care, Therapeutics | $20M–$275M |
|
Broadview Ventures
VC Fund
|
1 | United States, Switzerland, Canada | Series A, Seed, Series B | Health Care, Biotechnology, Medical Device | $1M–$45M |
|
+ND Capital
VC Fund
|
1 | United States, Switzerland, United Kingdom | Series B, Series C, Series A | Biotechnology, Health Care, Medical | $10M–$80M |
|
HealthCap
VC Fund
|
1 | United States, Sweden, France | Series B, Series A | Biotechnology, Health Care, Medical | $6M–$92M |
|
Lundbeckfonden Ventures
VC Fund
|
1 | United States, Denmark, United Kingdom | Series B, Series A, Series C | Biotechnology, Health Care, Therapeutics | $10M–$95M |
|
Sound Bioventures
VC Fund
|
1 | Denmark, United States, United Kingdom | Series A, Series B, Venture - Series Unknown | Biotechnology, Medical, Therapeutics | $3.6M–$83M |
|
PSV
VC Fund
|
1 | Denmark, United States, Sweden | Seed, Pre-Seed, Venture - Series Unknown | Software, Information Technology, Artificial Intelligence | $307k–$4.6M |
|
People Ventures
VC Fund
|
1 | Denmark, Sweden, United States | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, Health Care | $1M–$21M |
|
SLS Venture
VC Fund
|
1 | Denmark, United States, Sweden | Series C, Series A | Health Care, Biotechnology, Medical | $6.3M–$15M |
| Access all 117 investors in Denmark Life Science startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Denmark, United Kingdom
Investor stats
- Total investments: 415
- Round size: Series A $9.5M–$133M; Series B $15M–$135M; Series C $35M–$118M
- Lead/follow: 40% lead, 60% follow
- Last fund: May invest from a new fund soon — raised $165M in 2018
Portfolio highlights
- Windward Bio — Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with serious immunological diseases.
- SCHOTT Poonawalla — SCHOTT Poonawalla is a manufacturer of pharmaceutical containers, made of neutral glass tubing. The company provides parenteral packaging systems crafted from tubular glass, serving the pharmaceutical industry with a broad range of products including vials, pre-fillable syringes, ampoules, and cartridges.
- Vantia Therapeutics — Vantia Therapeutics is an emerging pharmaceutical company developing novel, small molecule drugs targeting large areas of unmet medical need. Its strong clinical pipeline includes VA106483 for nocturia and VA111913 for dysmenorrhoea, which directly target indications that together affect many millions of people, are poorly treated and representbillion dollar markets. Vantia's strategy is to develop its proprietary drug candidates through Phase II clinical testing and then commercialise through partnerships. The Company was founded in 2008 and is backed by specialist life science investors Novo A/S, SV Life Sciences and MVM Life Science Partners.
2xN operates as a venture capital firm.
Show more...Investment focus
- Industry: Software, Information Technology, Quantum Computing
- Stage:Seed, Series A, Series B
- Geography: Denmark, United States, United Kingdom
Investor stats
- Total investments: 36
- Round size: Seed $1.9M–$6.9M; Series A $6.4M–$63M; Series B $15M–$125M
- Lead/follow: 11% lead, 89% follow
- Last fund: Likely still investing — raised $120M in 2022
Portfolio highlights
- Kvantify — Quantum computing will revolutionize many aspects of computing. We can help your business harness the full potential of Quantum Computing and High-Performance Computing today.
- QSimulate — QSimulate is a simulation platform that solves pressing problems for the chemical and pharmaceutical industries. It aims to deliver best-time-to-solution algorithms to chemical and pharmaceutical industries to accelerate their computational R&D. It is headquartered in Cambridge, Massachusetts.
- Sparrow Quantum — Sparrow Quantum, a global leader in quantum photonic chip technology. Explore innovative solutions driving advancements in quantum computing, communication, and beyond. Stay ahead with cutting-edge technologies shaping the future.
BioInnovation Institute is a biotechnology startup that offers entrepreneurs and researchers in life science. Early-stage life science start-ups are supported with up to 10 million DKK in funding, business acceleration, network, labs, and office space. It helps to early-stage start-ups within human health and planetary health. The startup's mission is to use its knowledge, network, funding, and infrastructure to incubate world-class life science and catalyze the commercialization of new solutions through start-ups. BioInnovation Institute was founded in 2018 and is based in Denmark.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Convertible Note, Pre-Seed, Seed
- Geography: Denmark, Germany, Switzerland
Investor stats
- Total investments: 93
- Round size: Seed $532k–$1.8M; Pre-Seed $530k–$5.2M; Convertible Note $495k–$1.6M
- Lead/follow: 92% lead, 8% follow
Portfolio highlights
- Visibuilt — Visibuilt develops sustainable, bio-based asphalt binders made from mycelium. Replace fossil bitumen with visiBIT.
- Agrobiomics — Agrobiomics is a danish Agritech start-up, harnessing the power of soil bacteria and their metabolites as new biostimulants to help crops cope with abiotic stress such as drought.
- metaLead Therapeutics — metaLead Therapeutics is to develop this peptide as a next-generation Pb poisoning treatment.
Export and Investment Fund serves as a single point of contact for Danish firms seeking risk-tolerant government finance. serves as a single point of contact for Danish firms seeking risk-tolerant government finance. We aspire to help successful enterprises that can expand the Danish economy and green the world on a daily basis, guided by professionalism and an international perspective.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Seed, Pre-Seed, Series A
- Geography: Denmark, United States, Norway
Investor stats
- Total investments: 148
- Round size: Seed $395k–$11M; Pre-Seed $807k–$2.9M; Series A $5.9M–$84M
- Lead/follow: 36% lead, 64% follow
Portfolio highlights
- Cortas — Cortas is a tech-enabled Danish property management company that offers an end-to-end, institutional-grade management service for real estate portfolios. The company replaces traditional, fragmented real estate administration by combining a dedicated team of industry experts with a proprietary digital platform to streamline operations, compliance, and financial reporting.
- Onomondo — Onomondo is a global IoT network. Our IoT SIM and cloud platform future proof your devices with full data transparency, freedom to leave, and no third parties.
- Rodinia Generation — Rodinia Generation offers environmental clothes manufacturing technologies that helps to eliminate overproduction in the fashion sector.
Bioqube Ventures helps science succeed by turning discoveries into transformative medicines.
Show more...Investment focus
- Industry: Biotechnology, Therapeutics, Life Science
- Stage:Seed, Series A, Series B
- Geography: United States, France, Norway
Investor stats
- Total investments: 18
- Round size: Seed $5.7M–$24M; Series A $4M–$76M; Series B $23M–$108M
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- Actithera — Actithera is a molecular radiotherapeutic company that develops radioligand therapies. It translates medicinal chemistry insights into new radioligand therapies (RLTs) and applies various molecular design strategies, including covalent targeting and an isotope-agnostic philosophy, to invent RLTs with significant differentiation and largertherapeutic windows.
- Spica Therapeutics — Spica Therapeutics develops precision therapies that selectively target disease-driving macrophage subsets in oncology, fibrosis and chronic diseases.
- Primmune Therapeutics — Primmune Therapeutics is developing small molecule, orally-administered toll-like receptor 7 (TLR7) agonists to attack tumors and potentiate adaptive cancer immunotherapies, such as checkpoint inhibitors, to improve overall response rates and treatment durability.
Vaekstfonden – The Danish Growth Fund – is the Danish state's investment fund. We strive to improve access to risk capital to enable Danish businesses to innovate, and to generate growth and new jobs. In close collaboration with banks and domestic and international private investors, we finance companies from all sectors nation-wide. We can accompany you for the entire journey – from your company’s infancy through growth phases to expansion abroad and even to an initial public offering.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Seed, Venture - Series Unknown, Pre-Seed
- Geography: Denmark, United States, United Kingdom
Investor stats
- Total investments: 231
- Round size: Seed $830k–$4.9M; Pre-Seed $384k–$2.4M; Venture - Series Unknown $1.2M–$23M
- Lead/follow: 27% lead, 73% follow
- Last fund: Likely still investing — raised $343M in 2023
Portfolio highlights
- Advalight — Advalight is a young, dynamic company dedicated to providing high-quality laser equipment for dermatological treatments. The company has patented an innovative technology for use in the removal of vascular lesions, acne treatment, skin rejuvenation and many other skin-enhancing procedures. The ground-breaking product was launched the summer 2014.Advalight is based on five years of scientific work in the Physics Department at the Technical University of Denmark. The founders include two PhDs and it is their research that forms the basis of Advalight. The company's main focus is on research and development and with the right external partners we believe that the market for dermatological lasers will be transformed. Advalight is therefore seeking collaboration with external partners with established distribution and sales channels.
- Sigma Estimates — Sigma Estimates was founded in 2003 under the name CodeGroup and is less than ten years been the market leader in software solutions for the calculation.For Sigma Estimates is the main task to develop it, to encourage and improve the work of kalkulationsopgaver in the construction industry. But it must be seen in a larger context, and thereforeSigma also the ultimate tool when the company's work processes more efficient and streamlined.Sigma typically helps companies to reach a best practice to select the projects that are profitable and to foster knowledge sharing within the company.Sigma Estimates are more than any other has come to stand for quality and ease of use. The goal is to bring together IT knowledge with kalkulationsviden and have it all to go up to a higher level.
- Merus Audio — Merus Audio is an audio company that develops switching audio amplifiers. The developed audio amplifiers consist a multilevel audio amplifier technology, which is a combination of a multilevel switching topology and a dynamic power management scheme to improve efficiency and compactness. The company's product eximo MA12040/12040P andMA12070/MA12070P are used for home theater systems, TVs, sound bars, stereo systems, mobile phones, and portable media players. They cut down power losses during operations.Merus Audio was found by Mikkel Hoyerby, and Hans Andersen in 2010; and is headquartered in Herlev, Denmark.
Vaekstfonden makes equity investments in Danish companies with a track record as well as in young entrepreneurial, innovative enterprises with an ambition for global growth.
Show more...Investment focus
- Industry: Software, Biotechnology, Medical Device
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Denmark, United Kingdom, Iceland
Investor stats
- Total investments: 32
- Round size: Seed $1.2M–$9.1M; Series A $1.5M–$23M; Venture - Series Unknown $2.8M–$31M
- Lead/follow: 28% lead, 72% follow
Portfolio highlights
- Rokoko — Rokoko | Affordable high-end motion capture and animation tools for body, hand, and face capture + software with native integrations for all major animation software and game engines
- Kollektiv — Unleash your best self with tailored training plans, learning and support for running, swimming and cycling - from world-class-coaches and ex-athletes.
- Performativ — Performativ develops modern solutions for the asset and wealth management industry. Our clients span from small investment advisors to enterprise banks.
In the two decades since our founding, we have worked with hundreds of extraordinary European founders, and have raised eight funds totalling more than $3bn.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Financial Services
- Stage:Series A, Series B, Series C
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 482
- Round size: Series A $3.7M–$30M; Series B $9.5M–$100M; Series C $15M–$160M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — raised $615M in 2024
Portfolio highlights
- Duvo — Duvo brings your people, AI agents and existing systems together to map, run and improve your processes, with decisions, exceptions and results in one place.
- NewBay — NewBay enables operators and device makers to deliver a lifetime of digital content experiences across any connected device such as mobile, PC, tablets and TV. The NewBay white label software platform powers cloud-based services for storing, sharing, accessing and organizing digital content. NewBay enables customers to monetize a wide range ofbranded services such as social networking, photo and video albums, digital vault, notifications and converged messaging. NewBay is delivering highly successful commercial services for operators and device makers worldwide. Customers include T-Mobile, Telefonica O2, Orange, U.S. Cellular, AT&T, Telstra, Verizon and LG Electronics. NewBay is processing millions of messages daily and stores billions of media for live operator and device maker services. NewBay is based in Dublin, Ireland; Seattle, USA; Atlanta, USA; London, UK; Sydney, Australia and Seoul, South Korea. NewBay was founded in 2002. Following acquisition in 2011, NewBay is a wholly owned subsidiary of Research In Motion Limited (RIM).
- Socowave — Get full access to this domain. Easy, seamless transactions. Zero percent financing available.
Sunstone Life Science Ventures is an independent European venture capital investment firm. We enable and empower life science therapeutics innovations.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: Denmark, Sweden, Switzerland
Investor stats
- Total investments: 63
- Round size: Series A $5.5M–$61M; Series B $9.5M–$58M; Series C $4.1M–$63M
- Lead/follow: 16% lead, 84% follow
- Last fund: May invest from a new fund soon — raised $92M in 2019
Portfolio highlights
- Kynexis — Kynexis is leading the way in precision medicine, focusing on the treatment of cognitive impairment associated with schizophrenia (CIAS). Explore our innovative approach and our dedication to improving the lives of millions globally.
- Step Pharma — Step Pharma is a spin-off of Imagine Institute stemming from Pr. Alain Fischer’s research on genetic immunodeficiencies. Step Pharma is a joint venture between Imagine, a research and innovative healthcare institute, Sygnature Discovery, a leading provider of integrated drug discovery resource and expertise, and Kurma Partners, a major player inthe funding of healthcare and biotechnology in Europe.
- TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
Targeting critical European re-industrialisation technology across pioneering hardware sectors with capital efficient growth investments.
Show more...Investment focus
- Industry: Energy, Energy Storage, Renewable Energy
- Stage:Venture - Series Unknown, Seed
- Geography: Denmark, Germany, Sweden
Investor stats
- Total investments: 29
- Round size: Seed $3M–$8.7M; Venture - Series Unknown $4.5M–$9.8M
- Lead/follow: 72% lead, 28% follow
- Last fund: Likely still investing — raised $286M in 2024
Portfolio highlights
- Stabl Energy — Scalable battery storage systems for energy storage in industry and commerce made by STABL Energy help to utilise the full potential of renewable energies.
- Green Hydrogen Systems — GreenHydrogen believes that electrolysers have a great potential to become a core technology in green and renewable energy.
- Hybrid Greentech — Hybrid Greentech offers end-to-end profitable solutions for BESS projects, from detailed business case and sizing analysis to project development services, EPC management, and operations and optimization for multi-market revenue stacking.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Wellcome Trust is a medical research charity that funds research that aims to protect and improving human and animal health. It focuses on the fields of public engagement, investments, innovation, humanities, and social science. It was founded in 1936 and headquartered in London, England.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Grant, Series C, Series B
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 126
- Round size: Grant $1.6M–$10M; Series B $18M–$68M; Series C $10M–$127M
- Lead/follow: 40% lead, 60% follow
- Last fund: May invest from a new fund soon — raised $331M in 2018
Portfolio highlights
- Lario Therapeutics — Lario Therapeutics are developing first-in-class disease modifying treatments for severe neurological disorders. Precision Neuroscience Today.
- Wysa — Use Wysa to vent or just talk through negative thoughts and emotions. Let it help you cope with pandemic anxiety and lockdowns. It is anonymous, safe and free.
- Ineffable Intelligence — Ineffable Intelligence is an AI research company whose mission is to make first contact with superintelligence.
Seventure Partners is a French venture capital firm targeting in Tech/Digital and Life Sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion. Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with € 1 billion under management as of December 31, 2023. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations. Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors. The different funds/verticals on which Seventure Partners are focusing on today: - Life Sciences : Biotech, Healthcare, Nutrition - Tech/Digital : B2B SaaS, Fintech, Retailtech, Cybersecurity - Sports & Wellbeing - Blue Economy
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Series A, Series B, Seed
- Geography: France, United States, Germany
Investor stats
- Total investments: 281
- Round size: Seed $1.1M–$4.7M; Series A $3.3M–$24M; Series B $3.3M–$63M
- Lead/follow: 38% lead, 62% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Flexvelop — Flexvelop is a fintech transforming the way businesses finance essential business equipment. "Flexing" is an innovative combination of leasing, renting and bank-financing terms offering a kind of Hardware-as-a-Service solution. Embedded as a payment solution, partnered manufacturers, vendors and brands are actively offering"Flexing" to their b2b customers for financing new business equipment right at the point of sale and in online shops. Flexvelop is operating in the verticals of office-it, hospitality equipment, medical devices or fitness equipment throughout Germany. Well-known manufacturers like Lenovo, WMF, or LaMarzocco are using Flexing openly or as a white-label solution. SMB customers flex equipment to grow flexibly without the usual investment risk – saving liquidity, tax and a clean balance sheet. Flexvelop is using its patented in-house financing technology, promoting a more sustainable circular economy in the same time. Flexing becomes the new standard for business equipment procurement for SMBs throughout Germany, Europe and beyond.
- Kainova Therapeutics — Domain Therapeutics is a biopharmaceutical company focused on GPCR in immuno-oncology. Discover more than you think on our innovative cancer treatments tackling GPCR mediated-immunosuppression
- Vertero — Axial Therapeutics is a biotechnology company fundamentally changing the treatment of neurological diseases and disorders by harnessing groundbreaking science in the microbiome-gut-brain axis.
Northzone is a multi-stage venture capital firm operating across Europe and the US. Since 1996, it has backed more than 250 companies, including Spotify, Klarna, Spring Health, and Black Forest Labs.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, FinTech
- Stage:Series A, Series B, Seed
- Geography: United States, Sweden, United Kingdom
Investor stats
- Total investments: 375
- Round size: Seed $2.4M–$23M; Series A $4.5M–$32M; Series B $7.4M–$100M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely still investing — raised $1.1B in 2022
Portfolio highlights
- Duvo — Duvo brings your people, AI agents and existing systems together to map, run and improve your processes, with decisions, exceptions and results in one place.
- Rayon — Built for Speed. Designed for Teams.
- SolveAI —
BlueYard backs founders building the interconnected elements that can become the fabric of our future.
Show more...Investment focus
- Industry: Software, Biotechnology, Blockchain
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: United States, Germany, United Kingdom
Investor stats
- Total investments: 117
- Round size: Seed $1.5M–$13M; Series A $7M–$47M; Venture - Series Unknown $3.8M–$29M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Dubsof — Dubsof aggregates a business's fragmented operational data from emails, accounts, and spreadsheets to create a centralized database and build custom applications tailored to manage their specific daily workflows.
- Rapidata — Fast and reliable data labeling that powers your AI. Define your label needs now and get the results in minutes.
- Sensible Biotechnologies — Engineering cells to make better mRNA.
David is a technologist, the founder of Unity Technologies, non-exec director to others, and a restless entrepreneur with a passion for creating feedback loops between innovation and teams and products, applying new and old business models to changing industries, and pushing people to do the very best they can do. David's background is in programming, an assortment of university dabbling, creating companies, and helping entrepreneurs. He served as CEO of Unity Technologies since co-founding it in 2003 and until October 2014, with an unflinching vision to democratize game development, and to develop technology and business models for the next phase of the games industry. David Helgason attended the University of Copenhagen.
Show more...Investment focus
- Industry: Software, Gaming, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Denmark, Finland
Investor stats
- Total investments: 82
- Round size: Seed $1M–$8.5M; Pre-Seed $242k–$2.4M; Series A $5.4M–$30M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- ScyAI — ScyAI twins your assets and your coverage and shows exactly where they diverge.
- Noah — API-first stablecoin payments, enterprise-grade compliance and real-time settlements, powered by stablecoin technology.
- Flow Engineering — Requirements management, made collaborative
BIOFUND SpA, established by Fondazione Monte dei Paschi, Bank Monte dei Paschi , Finanziaria Senese di Sviluppo e Fidi Toscana, provides the initial seed capital for companies located in the incubator of Toscana Life Sciences in Siena.
Show more...Investment focus
- Industry: Genetics, Health Care, Health Diagnostics
- Stage:Pre-Seed, Seed
- Geography: Italy, Canada, Denmark
Investor stats
- Total investments: 6
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- RTM Diagnostika — Diagnostic microwave radio RTM-01-RESThe temperature and rate of growth of malignant tumorsCancer is the terrible disease of breast. That is why the full range of diagnostic measures in mammalogy aimed primarily at identifying it. It is known that the malignant tumor has a higher temperature compared with surrounding tissues. These data werefirst obtained Guture M. French scientist, who, after more than 550 invasive measurements demonstrated that malignancy is determined by its temperature is doubling time. Therefore, the most dangerous, rapidly growing tumors have a very high temperature. It is also known that thermal changes, usually preceded by structural changes. In particular, the thermal changes of the mammary glands come not a moment when the cancer reaches the required size, but much earlier. Studies have shown that even at the stage preceding the malignant growth, namely, when the cells have the expressed proliferation, accompanied by atypical changes, increases the density of microcapillary network, and as a consequence there is a local increase in temperature. Indisputable is the fact that patients with these changes have a high risk of malignancy. Many authors classify this condition as precancerous.The internal temperature - measure of angiogenesisIn 2003, Japanese scientists have shown that the temperature in the cancerous region determined by the density microcapillary network (microvessel density (MVD) [8]. This is the main parameter that characterizes angiogenesis. The density of the microcapillary network when proliferation atypia several times greater than the rate for normal tissues and characterizes the risk of malignancy. in addition, the microcapillary network density refers to the probability of transformation from noninvasive to invasive cancer, the probability of metastasis and tumor growth rate. Therefore, the internal temperature, as a measure of angiogenesis, provides important information about the development of cancer.
- DX Medical Solutions — DX Medical Solutions is a medical technology startup that uses machine learning and artificial intelligence to create efficient health monitoring and analysis systems. With a focus on providing personalized care, the company's product Diagnostix, collects data from a variety of sources and processes it through advanced algorithms to gain deepinsights into patient health. DX Medical Solutions contributes to better overall health outcomes while reducing the burden on the healthcare system.
- EXE Engineering — EXE-Engineering for Environment. Miglioriamo i sistemi produttivi per rendere meno impattanti le attività umane
Leading #lifesciences #venturecapital firm financing highly #innovative #biotechnology companies #worlwide.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: Spain, United States, Switzerland
Investor stats
- Total investments: 86
- Round size: Series A $3.8M–$65M; Series B $17M–$135M; Series C $29M–$83M
- Lead/follow: 28% lead, 72% follow
- Last fund: May invest from a new fund soon — raised $246M in 2020
Portfolio highlights
- AM Pharma — AM-Pharma B.V., a biopharmaceutical company, engages in the development and commercialization of therapeutics for human use in the Netherlands. It focuses in the pre-clinical and clinical development of novel therapeutics to treat inflammatory and infectious diseases. The company develops products based on endogenous proteins and protein derivedpeptides, as well as molecules that naturally occur in the human body. Its products include alkaline phosphatase for treatment of acute kidney injury and ulcerative colitis; and immune response amplifying peptide hLF1-11 for the treatment of drug resistant hospital acquired infections. The company was founded in 2000 and is headquartered in Bunnik, the Netherlands.
- Inbiomotion — Inbiomotion is focused on the development and commercialization of a biomarker that predicts metastasis to improve patients' quality of life by personalizing the adjuvant treatment of early stage breast cancer. Founded in 2010 by Dr. Roger Gomis, it is a spin-off of IRB Barcelona and ICREA research institutions.Inbiomotion's uniquediagnostic assay is based on a highly selective single gene biomarker. Data generated thus far suggests such biomarker can identify early stage breast cancer patients that will benefit from bisphosphonate adjuvant treatment improving their overall and invasive disease free survival. It can further predict at an early stage a patient's risk of metastases relapse from primary tumors. The selectivity of the lead biomarker has the potential to advance the clinical standard of care using personalized medicine.
- Anaconda BioMed — Anaconda Biomed, headquartered in Barcelona, Spain, is among the world's most innovative early stage medical technology companies. The company was founded by Dr. Ofir Arad and Dr. Marc Ribó in 2015, and is developing the ANCD BRAIN™, a novel 3rd Generation Stented Aspiration Thrombectomy System for the treatment of Acute Ischemic Stroke (AIS).
LF Investment is the investment arm of The Lauritzen Foundation, which is the parent company of the shipping companies J. Lauritzen (wholly-owned) and DFDS (42,8% holding). LF Investment has holdings in companies in the oil analysis, measuring equipment, software, biotechnology, and real estate sectors.
Show more...Investment focus
- Industry: Medical, Wellness, Health Care
- Stage:Series B, Series C
- Geography: Denmark
Investor stats
- Total investments: 4
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Minervax — We are MinervaX. A clinical stage biotech company focused on making a global impact by developing state-of-the-art vaccines.
Supporting purpose-driven founders solving systemic challenges to planetary health.
Show more...Investment focus
- Industry: Biotechnology, Food and Beverage, Manufacturing
- Stage:Pre-Seed, Seed, Series A
- Geography: Germany, United Kingdom, United States
Investor stats
- Total investments: 49
- Round size: Seed $3M–$8M; Pre-Seed $486k–$3.8M; Series A $15M–$17M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely actively investing — fresh fund, raised $48M in 2024
Portfolio highlights
- Apoha — Stealth stage start-up
- Triple Bio — Triple Bio is a biotech startup focused on improving productivity and sustainability in dairy and beef production using biological and data‑driven technologies.
- evasive robotics — EVASIVE ROBOTICS develops software and robotic systems for industrial automation. Its EvaLib technology coordinates multiple robots in shared workspaces and supports real-time motion planning. The company offers solutions for assembly, palletizing, bin picking, logistics, and intralogistics tasks. Its GESSBOT Duo platform combines a dual-arm automated guided vehicle with EvaLib software for handling, sorting, picking, and placing operations.
Bas Godska is based out of Amsterdam, Noord-Holland and is the Co-Founder of Netherlands for Ukraine. Bas previously worked at LinkPizza as an Angel investor. Bas Godska attended the University of Amsterdam.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Pre-Seed, Angel
- Geography: United States, The Netherlands, United Kingdom
Investor stats
- Total investments: 58
- Round size: Seed $300k–$2M; Angel $90k–$110k; Pre-Seed $90k–$2M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Helio AI — Automated AI-powered recruiting platform with ATS and gamified personality test. Reduce daily workload by 60% and hire top talents in a few clicks.
- Crosscheck — One structured audit record across scheduling, scoping, pre-audit, fieldwork, reporting, non-conformities, and technical review.
- JobHire.AI — JobHire.AI for job search. Your AI Career Assistant that helps you land an interview 10 times faster, match with top employers, and boost your career growth.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!A passion and vision for chemistry and biotechnology led Per (born 1958) to Novo A/S, where he started his career as a research chemist. He subsequently held several managerial positions developing products for the detergent industry and rose to Director for Application Technology in the company’s new enzyme development division in 1995.Hemoved to Raleigh, N.C., to head the company’s U.S. application technology unit in 1997, returning to Denmark three years later as Corporate Vice President of the Enzyme Development and Application division. In April 2000, Per merged the Research and Development division into the newly formed Enzyme Business R&D.Per assumed his current position following Novozymes’ demerger from Novo Nordisk in 2000. As chief science officer, he has helped Novozymes develop a unique industrial biotechnology platform which delivers solutions to meet customer needs and support growth.Per holds a M.Sc. in Chemical Engineering from Technical University of Denmark (DTU). Committed to promoting education and research within the sciences, he was appointed Honorary Professor at DTU’s Institute for Systems Biology in 2010 and became Chairman of the Board in 2013. He is also Chairman of the Young Scientists association in Denmark.Per’s current external positions also include Chairman, DTU, board member of DHI Group, board member of ARTs Biologics A/S, and member of the Danish Council for Research Policy.
Show more...Investment focus
- Industry: Biotechnology, Robotics, Biopharma
- Stage:Pre-Seed, Series A, Seed
- Geography: Denmark
Investor stats
- Total investments: 5
- Round size: Series A $5.9M–$20M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Visibuilt — Visibuilt develops sustainable, bio-based asphalt binders made from mycelium. Replace fossil bitumen with visiBIT.
- Octarine Bio — Octarine Bio is a world leading synthetic biology platform with a core mission to drive bio-based, sustainable solutions to address the most pressing planetary issues through innovation & exploration. Inspired by nature, to protect nature.
- Synamics Therapeutics — Synamics Therapeutics uses AI and predictive modeling for precision oncology and improved drug discovery. Our adaptive medicine approach helps prolong drug effectiveness and improves outcomes for patients with intractable cancers. Learn more about Synamics Therapeutics and how we leverage AI for personalized, adaptive cancer therapies.
Pelajari panduan pola game terbaru bersama KEDAI69 melalui informasi yang mudah dipahami untuk membantu menyusun strategi dan membuat pengalaman bermain lebih maksimal.
Show more...Investment focus
- Industry: Medical, Health Care, Genetics
- Geography: Denmark, United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Exiqon — Exiqon operates in two business areas: Life Sciences and Diagnostics. Exiqon Life Sciences, a leading provider of flexible solutions for RNA analysis. Exiqon’s research products are used by academia, biotech and pharmaceutical companies around the world to make groundbreaking discoveries about the correlation between gene activity and thedevelopment of cancer and other diseases. Exiqon Diagnostics collaborates with pharmaceutical and diagnostic companies to develop novel molecular diagnostic tests for early detection of diseases which can help physicians make treatment decisions based on the tools developed by Exiqon Life Sciences.
- Digital-Healthcare — Digital Healthcare is a health care company. The company has been acquired by EMIS Group.
Steen Riisgaard
Show more...Investment focus
- Industry: Biotechnology, Biopharma, Wholesale
- Stage:Pre-Seed, Series A
- Geography: Denmark
Investor stats
- Total investments: 3
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Visibuilt — Visibuilt develops sustainable, bio-based asphalt binders made from mycelium. Replace fossil bitumen with visiBIT.
- Octarine Bio — Octarine Bio is a world leading synthetic biology platform with a core mission to drive bio-based, sustainable solutions to address the most pressing planetary issues through innovation & exploration. Inspired by nature, to protect nature.
- Synamics Therapeutics — Synamics Therapeutics uses AI and predictive modeling for precision oncology and improved drug discovery. Our adaptive medicine approach helps prolong drug effectiveness and improves outcomes for patients with intractable cancers. Learn more about Synamics Therapeutics and how we leverage AI for personalized, adaptive cancer therapies.
The Redstone team is an international and diverse group of serial entrepreneurs, investors, investment professionals, tech analysts and data scientists.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, Finland, Switzerland
Investor stats
- Total investments: 179
- Round size: Seed $460k–$7.8M; Pre-Seed $1M–$4.4M; Series A $1.7M–$17M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely actively investing — fresh fund, raised $29M in 2026
Portfolio highlights
- FermLabs — Ferm Labs ingredient startup specializing in proprietary, high-yield bioprocessing platforms.
- LimX Dynamics — Zhuji Dynamics is a general-purpose footed robot company that focuses on the R&D and manufacturing of sports intelligence and footed robots
- Zhuji Dynamics — Zhuji Dynamics is a general-purpose footed robot company that focuses on the R&D and manufacturing of sports intelligence and footed robots
Purposeful and profitable capital for extraordinary ventures solving our world's greatest challenges.
Show more...Investment focus
- Industry: Software, Logistics, Quantum Computing
- Stage:Seed, Venture - Series Unknown
- Geography: Denmark, Vietnam
Investor stats
- Total investments: 3
- Round size: Seed $1.9M–$11M
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Kvantify — Quantum computing will revolutionize many aspects of computing. We can help your business harness the full potential of Quantum Computing and High-Performance Computing today.
- SmartSolar — SmartSolar is a Saigon-based EnergyTech company working to decarbonise Southeast Asia. With SmartSolar, businesses save on their electricity bill from day 1. SmartSolar is currently busy building the critical financing infrastructure to get SMBs equipped with solar energy. We help our customers save money and enable our partners to reach morecustomers. Renewable energy is at an inflection point across the region and we are on a mission to make it available for everyone.
Innovestor is an active Finnish investment manager, focusing on venture capital, real estate, and energy storage. We also offer corporate venturing services.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Venture - Series Unknown, Pre-Seed
- Geography: Finland, Sweden, Denmark
Investor stats
- Total investments: 98
- Round size: Seed $477k–$4.5M; Pre-Seed $204k–$2M; Venture - Series Unknown $529k–$5.1M
- Lead/follow: 55% lead, 45% follow
- Last fund: Likely still investing — raised $33M in 2023
Portfolio highlights
- Khoy — Khoy Company is a furniture company focused on designing and developing comfortable, user-friendly, and sustainable sofa beds. It combines functionality, comfort, and modern design to create versatile furniture for everyday living, with an emphasis on sustainability and space efficiency.
- AnaCardio — AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility and aims to improve clinical outcomes in heart failure.
- Bahn Express — Bahn Express is a global car transportation company that supports independent contractors while offering quick and easy auto shipping throughout Europe.
Industrifonden is a Nordic evergreen venture capital firm with a fund size of $600m, that focuses on early-stage technology and life science companies with international potential. The company works long term with the entrepreneurs we invest in, and have a strong track record of building game changing companies. Industrifonden-backed companies include tech companies Qlik, Arcam, Soundtrack Your Brand, Fishbrain, and life science companies CellaVision, Oncopeptides and AMRA.
Show more...Investment focus
- Industry: Biotechnology, Software, Information Technology
- Stage:Series A, Venture - Series Unknown
- Geography: Sweden, United States, Denmark
Investor stats
- Total investments: 205
- Round size: Series A $3.3M–$21M; Venture - Series Unknown $1.6M–$20M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Avtal24 — Avtal24 offers in an easily accessible manner agreements for both private individuals and companies. They believe in making the law available to everyone and they want everyone to have access to legal security. With us, you write agreements online or together with a lawyer by phone. Always at a fixed price. With high legal expertise, innovativetechnology and great focus on customer benefit and offer the market's most accessible legal services.Avtal24 was founded in 2004 and is headquartered in Stockholm, Sweden.
- Fibbl — Enhance your e-commerce store with high-quality 3D product visualization for footwear. Scale 3D, AR, and virtual try-on experiences to boost engagement and conversions.
- Trackpaw Scientific — Stress-free 24/7 home-cage monitoring of weight, activity and behaviour for every animal, without handling and without blind spots.
Amino Collective is an institutional venture capital firm investing at seed stage in health and bio companies. They help bring life-changing ideas to life by backing, connecting, and advancing our collective of entrepreneurs and scientists. The firm intends to invest in the sectors of biology, biotech, health tech, science, digital health, life science, and synthetic biology.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 47
- Round size: Seed $2.4M–$14M; Pre-Seed $125k–$10M; Series A $12M–$37M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Calibre — Calibre uses causal AI in conjunction with clinical expertise to help people understand what is truly influencing their health and how to modify it.
- Frontier Computing — Frontier Computing is a biocomputing company growing large-scale neuronal tissue, living hardware with memory baked in at the cellular level.
- Tandem Health — Focus on providing care, while Tandem helps you easily write medical notes directly after the patient consultation.
Danske Bank is a Nordic universal bank offering a full range of banking services. It was founded 5 October 1871 as Den Danske Landmandsbank, Hypothek- og Vexelbank i Kjøbenhavn (The Danish Farmers' Bank, Mortgage and Exchange Bank of Copenhagen). It is headquartered in Copenhagen, Denmark and is one of the major retail banks in the northern European region with over 5 million retail customers. Danske Bank was number 454 on the Fortune Global 500 list for 2011.
Show more...Investment focus
- Industry: Manufacturing, Energy, Financial Services
- Stage:Post-IPO Debt, Debt Financing
- Geography: Sweden, Finland, United Kingdom
Investor stats
- Total investments: 67
- Round size: Post-IPO Debt $3.4M–$571M; Debt Financing $1.1M–$928M
- Lead/follow: 39% lead, 61% follow
Portfolio highlights
- Bonava — Bonava is a real estate company. They offer apartments and single-family housing to consumers and rental apartments to investors. It constructs several types of homes, such as multi-family housing, single-family homes, and semi-detached houses with various types of tenure.
- VOI Technology — Voi is a micromobility company operating e-bikes and e-scooters in 150+ cities. EBIT-profitable since 2024.
- Donnelly Group — Donnelly Group is an automotive company that specializes in the selling of a range of new and used cars as well as offers repair services.
Delphinus Venture Capital is a venture investment management firm.
Show more...Investment focus
- Industry: Health Care, Food and Beverage, Wellness
- Stage:Seed, Venture - Series Unknown, Pre-Seed
- Geography: Denmark
Investor stats
- Total investments: 12
- Round size: Seed $1.7M–$3.4M; Venture - Series Unknown $1.9M–$8.1M
- Lead/follow: 50% lead, 50% follow
- Last fund: Likely actively investing — fresh fund, raised $94M in 2025
Portfolio highlights
- Alcolase — Alcolase is developing a liposomal enzyme system designed to support alcohol metabolism in the stomach. Copenhagen-based biotech backed by Ada Ventures and Delphinus Venture Capital.
- Oktogrid — Electrification is taking place at a rate, where conventional methods for inspection, maintenance, and congestion management no longer match the new energy scenario. Distribution transformers are ageing blind spots today with no access to online, real-time performance data. This is because getting access to data is hard. We have solved this problem.
- Ardos — Ardos is a developer of radiotherapy software designed to enhance cancer treatment.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!We believe the talent to build great companies comes from anywhere. A global venture capital firm that invests in local founders. As a multi-stage, sector-focused firm, GGV focuses on seed- to growth-stage investments across Social/Internet, Enterprise Tech, and Smart Tech sectors.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Series B, Series A, Series C
- Geography: United States, China, Singapore
Investor stats
- Total investments: 883
- Round size: Series A $4.9M–$63M; Series B $11M–$60M; Series C $15M–$150M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — raised $147M in 2024
Portfolio highlights
- CYGNUSEMI — Cygnus Semi is a semiconductor chip technology company that focuses on 5G IoT applications.
- Startorus Fusion — Startorus Fusion focuses on developing and commercializing fusion energy technologies, aiming for controllable device miniaturization, commercialization, and fast iteration, integrating design, R&D, operation, and maintenance.
- SiliconFlow — Silicon Mobile Technology is an AI infrastructure company that specilaizes in large models inference and deployment system to reduce the cost in the AIGC and LLM industries.
Teknoinvest is a premier Scandinavian venture capital company. They invest in areas of emerging technologies within the ITC and Life Sciences sectors. Their main geographical scope is Scandinavia and the USA. Teknoinvest was established as the first venture capital investment company. Teknoinvest is one of the most successful VC´s in Scandinavia according to track record of value created for their investors.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series B, Series A
- Geography: Sweden, Norway, United States
Investor stats
- Total investments: 25
- Round size: Series A $1.2M–$12M; Series B $6M–$31M
- Lead/follow: 8% lead, 92% follow
- Last fund: May invest from a new fund soon — raised $53M in 2002
Portfolio highlights
- GLO — glō is a venture-backed company focused on the development and commercialization of advanced LED display products using nanotechnology. The unique nanotechnology is based on 11 years of research at Lund University’s Nanometer Structure Consortium. Headed by Professor Lars Samuelson, one of the world’s leading scientists in this field, who haspublished more than 500 papers related to this technology.glō's first office is in Lund, Sweden, where basic material research continues for the next generation nanotechnology. glō's research and product development along with pilot fabrication operation is carried out at glō-USA in Sunnyvale, California. In 2016, glō established an Asia office in Taipei, Taiwan, one of the largest and fastest-growing regions for LED lighting and display applications.glō's technology sidesteps the technical limitations of current planar LED technology. It allows for the creation of highly efficient, stable and ultimately unique red, green, blue (RGB) emitters out of one material system. It aims to achieve the industry’s best color stability and ultimately enables the growth of red, green and blue emitters on the same wafer. Highly-efficient white LEDs with high color rendering will be possible without the need for phosphor conversion. It is the next enabling technology for advanced display, illumination and automotive applications.glō nanowire light-emitting diodes (nLEDs) are based on its proprietary hetero-structured semiconductor nanowire epitaxial growth and process technologies for which standard manufacturing equipment and materials can be utilized.glō currently holds over 175 patents across US, Europe and Asia. These patents are not subject to any cross-licensing with the LED oligopoly. The glō team is constantly strengthening its intellectual property position in this technology and related applications.
- SantoSolve — SantoSolve is developing topical analgesic products based on non-radioactive strontium as the active substance. The Development program was initiated based on experimental clinical use of strontium-based products showing evidence of strong local analgesic effects on several localized pain conditions of both nociceptive and neuropatic origin. Nosignificant adverse effects associated with the treatment was reported.The company’s lead product, 2PX, is topically administered, utilizing dermal penetration enhancers for delivery of the active agent to its subdermal site of action. Phase I safety and pharmacology studies showed the active agent to have low systemic bioavailability, and only few and minor adverse effects were observed at the site of administration. In open label Phase II clinical trials, the product has shown strong analgesic effect in both nociceptive and neuropatic pain conditions. In follow up, placebo controlled trials, the analgesic effect of the product has been further documented. In the company’s most advanced pain indication under study, osteoarthritis, the company has recently completed the Phase II program.These trials supports the open label results and document statistically that the analgesic effect in patients treated with 2PX is superior to that observed with placebo treatment.
- Sol Voltaics — Explore editorial solar guides, product analysis, comparisons and buying advice at SolVoltaics.com. Grab verified deals on Best Solar Brands.
p53 identifies and invests in innovative healthcare companies, particularly in the fields of biotechnology and medical devices.
Show more...Investment focus
- Industry: Biotechnology, Medical, Life Science
- Stage:Series A
- Geography: Norway, Denmark, The Netherlands
Investor stats
- Total investments: 3
- Round size: Series A $30M–$81M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- RougeTx — RougeTx is a Netherlands-based biotech developing first-in-class small-molecule therapies for vascular diseases caused by pericyte dysfunction. Its lead candidate, RTX-001, targets hereditary haemorrhagic telangiectasia (HHT), an inherited disorder involving fragile blood vessels and recurrent bleeding.
- Calluna Pharma — Join Calluna Pharma to transform therapeutics for inflammatory and fibrotic diseases. With a robust pipeline, seasoned leadership, and strategic alliances, we can revolutionize patient care.
- Teitur Trophics — Teitur Trophics is a biotech company developing circular peptides for neurodegenerative diseases. The company was founded in 2020 and is headquartered in Aarhus, Denmark.
Innovation Fund Denmark invests in the development of new knowledge and technology creating growth and employment in Denmark. The Fund focuses on societal challenges, strengthens research, and increases innovation commitment within private companies. The Fund provides risk capital that enables cutting-edge initiatives to achieve results substantially impacting the Danish society. Innovation Fund Denmark is also responsible for the future societal partnerships, where companies, universities, and public authorities will work together on challenges facing the society today.
Show more...Investment focus
- Industry: Software, Biotechnology, SaaS
- Stage:Grant, Pre-Seed, Seed
- Geography: Denmark, United States
Investor stats
- Total investments: 98
- Round size: Seed $66k–$2.1M; Grant $38k–$1.1M; Pre-Seed $64k–$1.6M
- Lead/follow: 34% lead, 66% follow
Portfolio highlights
- Prezio — Electricity prices with grid fees, taxes and levies, for every 15 minutes, through one API.
- PerPlant — PerPlant gives tractors the ability to see every plant. AI-powered cameras that cut input costs by 50% on average.
- Tailwind Biotech — AI-powered synthetic DNA design services for improved strain development. We use Artificial Intelligence to help biotech companies achieve more effective and more efficient bioproduction processes. Our technology designs best-in-class synthetic DNA Promoters and Terminators, and performs gene codon optimizations that help to maximise biomanufacturing yields while reducing development costs.
Seed Capital invests in Danish tech businesses with global ambitions. We are focused on "late seed"-stage companies, typically investing 2-4 MEUR in rounds of 2-10 MEUR. Proud backers of Trustpilot, Vivino, Lunar, Templafy, Dixa, Forecast, and many other great companies.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Denmark, United States, United Kingdom
Investor stats
- Total investments: 216
- Round size: Seed $549k–$5.2M; Series A $3.8M–$17M; Venture - Series Unknown $580k–$5.1M
- Lead/follow: 29% lead, 71% follow
- Last fund: May invest from a new fund soon — raised $74M in 2021
Portfolio highlights
- Expanite — Expanite has developed a series of unique solutions for surface-hardening of stainless steel. With the opportunity of processing most common stainless steel alloys - either in-house or at Expanite's treatment centre - the company offers significantly improved corrosion, wear, fatigue and scratch resistance
- Minervax — We are MinervaX. A clinical stage biotech company focused on making a global impact by developing state-of-the-art vaccines.
- Reapplix — Reapplix ApS, a research and development company, identifies blood-derived proteins that improve wound healing, isolates them, and reapplies them to patients with chronic wounds. The company was founded in 2008 and is based in Birkerod, Denmark.
Korys is the name chosen by the Colruyt family for their investment structure. The name Korys is derived from the Latin word for hazelnut tree – Corylus - which is at the origin of the Colruyt name.Their multi-disciplinary approach enables us to create a well-balanced, diversified portfolio of listed stocks and bonds, private equity funds, anddirect participations in small and medium-sized companies. Through their investments, they aim to make a positive impact on people and the planet, while generating attractive returns. A “three P” approach (People, Planet, Profit) forms the cornerstone of their investment strategy. They invest for the long term, as they realize that it takes time to achieve the sustainable impact they are aiming for. They focus their investments in sectors in which they have built substantial expertise as a team: Cleantech, consumer goods & retail and life sciences.
Show more...Investment focus
- Industry: Biotechnology, Renewable Energy, Information Technology
- Stage:Series B, Series A
- Geography: Belgium, The Netherlands, Germany
Investor stats
- Total investments: 48
- Round size: Series A $4.4M–$13M; Series B $6.4M–$50M
- Lead/follow: 46% lead, 54% follow
Portfolio highlights
- Entrix — Entrix is an optimisation and trading platform for grid-scale battery storage that accelerates the transition towards a clean energy future. Our mission is to enable the most effective use of green energy and to ensure the reliability of the future energy system. We provide state-of-the-art technology and services to both asset owners and potentialinvestors across the globe.
- OroraTech — From safeguarding forests and ecosystems to protecting communities and critical assets, OroraTech's advanced technology and reliable insights address challenges, mitigate risks, and drive meaningful impact.
- Ona Therapeutics — Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. Founded in 2019 by Salvador Aznar-Benitah and Valerie Vanhooren, it was a spin-off from ICREA and Advanced Studies, and the IRB Institute for Research in Biomedicine.
We invest in growth companies in the "late-stage venture/growth capital" phase, focussed on the technology and healthtech sectors.
Show more...Investment focus
- Industry: Health Care, Manufacturing, Robotics
- Stage:Series B, Series C
- Geography: Switzerland, Germany, Belgium
Investor stats
- Total investments: 30
- Lead/follow: no public data
Portfolio highlights
- Fotokite — Specialized actively tethered UAS built for First Responders, providing immediate situational awareness of an emergency scene.
- Memo Therapeutics — Memo Therapeutics AG (MEMO) is an innovator in the field of antibody discovery and immune repertoire analysis.Its MemoMAB™ platform creates a recombinant in vitro copy of an individual’s B cell / antibody repertoire, which is then banked as a library. The resulting unique, large and relevant antibody libraries represent the individual’simmune repertoire and are expected to contain an unprecedented number of relevant and rare antibodies. This leads to entirely new possibilities in immune repertoire analysis and antibody discovery.MemoMAB™ is deployed in proprietary antibody lead discovery programs and is made available in collaborations.
- NIL Technology ApS — NIL Technology is an optical solutions company designing, developing, and manufacturing optical elements and components using high-precision nanoscale features
FSG (Fåhraeus Startup and Growth) is a Lund-based venture capital firm investing at the intersection of life science and tech, including digital health, medtech, diagnostics and life science tools. It invests €1–6M per company from Seed to Series A, selectively Series B.
Show more...Investment focus
- Industry: Medical, Biotechnology, Genetics
- Stage:Seed, Series A
- Geography: Sweden, Denmark, Finland
Investor stats
- Total investments: 8
- Round size: Seed $772k–$2.7M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Aplagon — Aplagon is committed to bringing unique, effective antithrombotic medicines with important safety advantages to patients with unmet needs.
- Fida Biosystems — Quantification and characterisation of complex biology made simple. Study molecular interactions in solution, with only nanoliters of sample. Used by industry leaders.
- Trackpaw Scientific — Contributing to the development of safe and effective pharmaceuticals at increased speed and quality by digitalising the preclinical study landscape.
Verve Ventures has invested in more than 140 science and technology startups. We support visionary and resilient entrepreneurs from day one and are a reliable partner for the entire journey. We typically invest EUR 1-3m in early as well as later stage rounds of European high tech startups.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Series A, Seed, Series B
- Geography: Switzerland, Germany, France
Investor stats
- Total investments: 230
- Lead/follow: no public data
Portfolio highlights
- Otoqi — Otoqi is a vehicle delivery platform that develops connected services and logistics solutions for the automotive professionals.
- tozero — Truly bringing lithium-ion battery waste tozero by recovering all critical matierlas, like lithium, nickel, cobalt, manganese, and graphite.
- Orakl Oncology — Cultivated with love by the Orakl team.
ATP is a self-governing institution, established by the Folketing by law in 1964. ATP's Board of Directors consists of equal representatives of employers and employees and an independent chairman of the board. The ATP Group has approx. 3,000 employees. ATP is headquartered in Hillerød, customer service centers in Frederikshavn, Holstebro,Haderslev, Vordingborg, Lillerød and Hillerød, as well as offices in Copenhagen, Allerød and New York.
Show more...Investment focus
- Industry: Health Care, Health Diagnostics, Software
- Stage:Series B
- Geography: Denmark
Investor stats
- Total investments: 5
- Lead/follow: no public data
Portfolio highlights
- DSV — Connect your business with the world: Global transport and logistics - road, air, sea, rail freight and warehousing. Contact us today.
- MedTrace Pharma — MedTrace develops a hardware platform (MT-100) that automates the production and injection of the gold standard tracer 15O-water into the patient. MedTrace also develops an analytical software platform to interpret the results from the PET scanner.By use of 15O-water, doctors will increase sensitivity in the analysis of the patient while at thesame time increasing patient throughput up to a factor of 4 compared to today's clinical workhorse.
- Visiopharm — Visiopharm image analysis and stereology software has become the preferred Quantitative Digital Pathology solution for leading biopharmaceutical companies, contract research organizations (CRO), academic medical centers, research institutes, and hospitals all over the world. Recently, Visiopharm has expanded to include ONCOtopix™ Dx a robustsolution for cancer diagnostics with CE-IVD algorithms for the breast panel, integrated LIS driven workflow, and Virtual Double Staining. Their software is featured in over 800 scientific publications, and is compatible with leading slide scanner manufacturers, data management software, and a wide variety of microscopes and cameras.Visiopharm, a privately owned company, was founded in 2001 by the Managing Director, and Chief Executive Officer, Michael Grunkin and the Chief Technical officer, Johan Doré Hansen, who both have a strong scientific and practical background in image analysis.Their company has grown into an international business with over 500 licenses in more than 30 countries. Their growing network of authorized distributors and partners support the growth of Visiopharm solutions on several continents including North America, Europe and Asia. Their headquarters is located in the Medicon Valley of Denmark, with a branch office in the Netherlands, and a North America office in Broomfield, Colorado.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Seed-to-A engineers. We invest in techdriven companies in the Nordics and Europe.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: Denmark, United Kingdom, Germany
Investor stats
- Total investments: 51
- Round size: Seed $1M–$4.3M; Pre-Seed $500k–$3.1M; Series A $10M–$16M
- Lead/follow: 53% lead, 47% follow
- Last fund: Likely still investing — raised $72M in 2024
Portfolio highlights
- ParlayX — ParlayX is a non-custodial institutional trading infrastructure built for prediction markets.
- Zellify — Create high-converting onboarding flows outside the App Store. Launch no-code funnels, run A/B tests, and turn web traffic into mobile subscriptions
- Pie Systems — Pie Systems - Easy tax free shopping and VAT refunds for merchants, business owners, travelers, and tourists through our web, iOS, and Android Pie VAT app. No forms, no waiting in line, and higher refunds.
RA Capital Management is an investment advisor based in Boston specializing in the life-sciences and drug development sectors. The company's team has been investing since 2002 and is comprised of professionals with training in biology, chemistry, and medicine and also has industry and business development experience at the executive and boardlevels. The company invests in companies with promising technologies and products.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series B, Post-IPO Equity, Series A
- Geography: United States, United Kingdom, China
Investor stats
- Total investments: 578
- Round size: Series A $20M–$128M; Series B $27M–$151M; Post-IPO Equity $35M–$275M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely actively investing — fresh fund, raised $120M in 2025
Portfolio highlights
- Serapha Bio —
- Windward Bio — Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with serious immunological diseases.
- Lisata Therapeutics — Lisata is a clinical-stage pharmaceutical company dedicated to improving lives through the discovery, development, and commercialization of innovative medicines.
Broadview Ventures, Inc. (Broadview) was established in 2008 as a new program conceived by the Leducq family. Through Broadview, the trust will work to accelerate the development of promising technology in cardiovascular and neurovascular disease through targeted investment in and support of early stage technology ventures. The Foundation Leducq, based in Paris, France, is the beneficiary of a charitable trust. In order to further the Foundation Leducq's mission in cardiovascular and neurovascular disease, the trust has made funds available to Broadview to develop a program which will promote early state technology in these fields through investments, licensing agreements and consortium funding arrangements, as well as professional, management and consulting support. With this initiative the trust joins other leaders in the venture philanthropy movement in seeking creative solutions to the problem of what is commonly referred to as the 'translational gap', a significant component of which is a lack of funding at a critical moment in the development of new technology and science.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Seed, Series B
- Geography: United States, Switzerland, Canada
Investor stats
- Total investments: 86
- Round size: Seed $1M–$18M; Series A $1M–$20M; Series B $2.5M–$45M
- Lead/follow: 27% lead, 73% follow
Portfolio highlights
- Adient Medical — Medical Devices that Automatically Vanish - Adient Medical is leading the development of an absorbable vascular filter for the prevention of pulmonary embolism.
- HAYA Therapeutics — Pioneering next-generation therapies for fibrotic diseases. Learn more about our approach here.
- Viridian Therapeutics (Formerly MiRagen Therapeutics) — Viridian Therapeutics is leveraging core expertise in antibody discovery to develop optimized treatments for rare autoimmune conditions
+ND Capital (NanoDimension) is a venture capital firm founded in 2002 that invests in disruptive technologies across the life, physical, and data sciences.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series C, Series A
- Geography: United States, Switzerland, United Kingdom
Investor stats
- Total investments: 81
- Round size: Series A $10M–$60M; Series B $15M–$80M; Series C $12M–$72M
- Lead/follow: 32% lead, 68% follow
- Last fund: May invest from a new fund soon — raised $335M in 2019
Portfolio highlights
- SiMa.ai — SiMa.ai scaling physical ai across across robotics, automotive, industrial automation, aerospace & defense, smart vision, and healthcare.
- SPARK Microsystems — SPARK Microsystems is a fabless semiconductor company that is leading the way towards ultra-low power wireless communications for the Internet of Things revolution. With its patented technologies, SPARK Microsystems will bring to market a high performance wireless transceiver that allows for orders of magnitude improved power consumption andlatency while providing higher data rates than competing technologies. For more information, please visit www.sparkmicro.com.
- Lightcast Discovery — Flexible control over droplet number, occupancy, location and movement. Enabling efficient, multi-step workflows with unprecedented flexibility.
HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A
- Geography: United States, Sweden, France
Investor stats
- Total investments: 141
- Round size: Series A $6M–$73M; Series B $12M–$92M
- Lead/follow: 26% lead, 74% follow
- Last fund: Likely still investing — raised $179M in 2024
Portfolio highlights
- Neobiomics — Neobiomics is a Swedish life-science company that develops nutritional products for preterm infants and neonatal care. Its best-known products include ProPrems® and NeoMega36®.
- AMRA Medical — AMRA Medical is a digital health company transforming medical research and clinical care using rapid whole-body MRI technology.
- Ultragenyx Pharmaceutical — Ultragenyx is focused on developing first-ever approved treatments for rare and ultrarare diseases and moving the rare disease community forward.
Lundbeckfond Ventures is an evergreen life science venture fund established in the autumn of 2009 and wholly owned by the Lundbeck Foundation. The structure as an evergreen fund allows flexibility in the investment approach and the possibility, when appropriate, to take a long-term perspective in the investments. On an annual basis, Lundbeckfond Ventures invests up to € 50 million. Lundbeckfond Ventures is a financially driven venture fund generating returns to support the group's activities and operating independently from the Lundbeck Foundation’s controlling ownerships in H. Lundbeck A/S, ALK-Abelló and Falck.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series B, Series A, Series C
- Geography: United States, Denmark, United Kingdom
Investor stats
- Total investments: 74
- Round size: Series A $10M–$50M; Series B $20M–$95M; Series C $10M–$53M
- Lead/follow: 32% lead, 68% follow
Portfolio highlights
- Kvantify — Quantum computing will revolutionize many aspects of computing. We can help your business harness the full potential of Quantum Computing and High-Performance Computing today.
- SNIPR Biome — We are the CRISPR Microbiome Company; Our mission is to develop CRISPR-based medicines that give hope for effective and safe treatment of difficult-to-treat diseases in the future.
- Women in Life Science Denmark — WiLD is a networking platform for women in senior positions in business and academia that is motivating and focused on science.
Sound Bioventures is a venture capital fund investing in clinical stage companies.
Show more...Investment focus
- Industry: Biotechnology, Medical, Therapeutics
- Stage:Series A, Series B, Venture - Series Unknown
- Geography: Denmark, United States, United Kingdom
Investor stats
- Total investments: 14
- Round size: Series A $18M–$83M; Series B $37M–$71M; Venture - Series Unknown $3.6M–$26M
- Lead/follow: 57% lead, 43% follow
- Last fund: Likely still investing — raised $124M in 2022
Portfolio highlights
- AnaCardio — AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility and aims to improve clinical outcomes in heart failure.
- Breye Therapeutics — Breye Therapeutics, a Danish-based biopharmaceutical firm in the clinical stages, is working to provide cutting-edge oral treatments for the management of retinal vascular diseases.
- Cytospire Therapeutics — Cytospire Therapeutics is bringing forward a portfolio of next generation immune cell engagers.
PSV cares about a conscious future. As a venture house, our mission is to clear the path for founders who build companies that matter. Our hybrid setup, comprising PSV Foundry, PSV Lab, and two unique venture funds, PSV Tech and PSV Hafnium, sets us free from adhering to a singular method. Rather we rethink existing ways and models to maximise our impact beyond any individual firm or investment. Together, we can punch above our weight.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: Denmark, United States, Sweden
Investor stats
- Total investments: 154
- Round size: Seed $506k–$4.6M; Pre-Seed $307k–$2.5M; Venture - Series Unknown $513k–$3.2M
- Lead/follow: 36% lead, 64% follow
- Last fund: May invest from a new fund soon — raised $64M in 2020
Portfolio highlights
- Thiax — ThiaX maps the strain and crystallinity in polymer and composite materials using cutting-edge X-ray diffraction (XRD) technology.
- spektr — Automate KYB, KYC onboarding, risk monitoring, and case management, reducing false positives and manual work for faster, more secure processes.
- Acodyne — Heavy-lift eVTOL cargo UAVs. Heavy payloads, high speed, autonomous flight.
We invest ourselves and money into early-stage founders. Operational VC based in Copenhagen, backing pre-seed and seed tech companies across the Nordics.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Pre-Seed, Series A
- Geography: Denmark, Sweden, United States
Investor stats
- Total investments: 38
- Round size: Seed $1.1M–$4M; Pre-Seed $1M–$3.3M; Series A $3.5M–$21M
- Lead/follow: 63% lead, 37% follow
Portfolio highlights
- Alrik — Turn your logistics into a competitive advantage and take control of your emissions. We help building material suppliers revolutionize their workflows.
- plinto — Plinto develops AI software for financial controlling and invoice analysis. Its virtual controller connects to enterprise resource planning systems and document repositories such as SharePoint, OneDrive, and Google Drive. The platform compares transactions with contracts, payment history, budgets, and business expectations to identify discrepancies and invoice outliers. It supports invoice line-item verification, vendor compliance checks, ledger posting review, spend monitoring, and financial anomaly detection.
- Pandektes — Search, verify, and rely on the law. Pandektes vast database combined with industry-leading search means more firepower in every legal analysis.
SLS Venture, a Scandinavian-based venture capital company, is the result of the merger of the life science team from The Sixth Swedish National Pension Fund, Medicon Valley Capital and Innoventus. The fund is one of the largest investment funds in Scandinavia in the life science sector with approx. € 270 M (USD 325 M) under management.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series C, Series A
- Geography: Denmark, United States, Sweden
Investor stats
- Total investments: 7
- Round size: Series C $6.3M–$15M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- AdvanDx — I found a great domain name for sale on Dan.com. Check it out!
- OxThera — OxThera is a biopharmaceutical company with products in late stage clinical development focusing on Primary and Secondary Hyperoxaluria. OxThera’s intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria, and enzymes. Oxabact® holds Orphan Drug designations in Europe and in the US for thetreatment of primary hyperoxaluria.
- Action Pharma — Providing a surprisingly human shopping experience. Trusted and secure. Millions of domains to choose from.
Life Science Investor funding in Denmark at a glance
Stats across 92 deals from 117 investors.
Access all 117 investors in Denmark Life Science startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Life Science Investors in Denmark investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 117 investors investing in Denmark Life Science startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!